A safety signal of somnambulism with the use of antipsychotics and lithium: A pharmacovigilance disproportionality analysis

Analysis of 5784 cases found significant association of somnambulism or sleep‐related eating disorder for second‐generation antipsychotics (Proportional Reporting Ratio 3.44, 95% CI 3.13) & lithium (2.03; 1.22; 3.37), but not for first‐generation antipsychotics (0.99; 0.68; 1.44)

British Journal of Clinical Pharmacology